These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 782731)

  • 1. Augmentation of specific macrophage-mediated cytotoxicity: correlations with agents which enhance antitumor resistance.
    Schultz RM; Papamatheakis JD; Stylos WA; Chirigos MA
    Cell Immunol; 1976 Aug; 25(2):309-16. PubMed ID: 782731
    [No Abstract]   [Full Text] [Related]  

  • 2. Nonspecific macrophage activation by systemic adjuvants. Evaluation by lysosomal enzyme and in vitro tumoricidal activities.
    Bruley-Rosset M; Florentin I; Khalil AM; Mathé G
    Int Arch Allergy Appl Immunol; 1976; 51(5):594-607. PubMed ID: 786904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of a new cell surface antigen on activated murine macrophages.
    Kaplan AM; Mohanakumar T
    J Exp Med; 1977 Nov; 146(5):1461-6. PubMed ID: 925608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo and in vitro macrophage activation by systemic adjuvants.
    Bruley-Rosset M; Florentin I; Mathé G
    Agents Actions; 1976 Feb; 6(1-3):251-5. PubMed ID: 782207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The second generation of EORTC-ECIG experimental screening for systemic immunity adjuvants. Its significance for cancer immunotherapy. A comparison of BCG and its hydrosoluble extract.
    Mathe G; Halle-Pannenko O; Florentin I; Bruley-Rosset M; Kamel M; Hiu IJ; Bourut C
    Eur J Cancer (1965); 1975 Nov; 11(11):801-7. PubMed ID: 767112
    [No Abstract]   [Full Text] [Related]  

  • 6. BCG inhibition of murine leudemia: local suppression and systemic tumor immunity require different doses.
    Bartlett GL; Purnell DM; Kreider JW
    Science; 1976 Jan; 191(4224):299-301. PubMed ID: 1108198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Water-soluble and lipid-free fraction from BCG with adjuvant and antitumour activity.
    Hiu IJ
    Nat New Biol; 1972 Aug; 238(86):241-2. PubMed ID: 4562114
    [No Abstract]   [Full Text] [Related]  

  • 8. Lack of biological significance of in vitro Brugia malayi microfilarial cytotoxicity mediated by Propionibacterium acnes ("Corynebacterium parvum")-and Mycobacterium bovis BCG-activated macrophages.
    Fanning MM; Kazura JW
    Infect Immun; 1986 May; 52(2):534-7. PubMed ID: 3516877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of cell-wall skeleton of Mycobacterium bovis BCG on cell-mediated cytotoxicity in tumor-bearing mice.
    Taniyama T; Azuma I; Aladin AA; Yamamura Y
    Gan; 1975 Dec; 66(6):705-9. PubMed ID: 817955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy of guinea pig cancer with BCG.
    Zbar B
    Johns Hopkins Med J Suppl; 1974; 3():121-30. PubMed ID: 4608693
    [No Abstract]   [Full Text] [Related]  

  • 11. Antitumor activity of cell-wall skeleton of Propionibacterium acnes C7 in mice and guinea pigs.
    Azuma I; Yamawaki M; Yoshimoto T; Saiki I; Uemiya M; Tanio Y; Tokuzen R; Yasumoto K; Yamamura Y
    Gan; 1979 Dec; 70(6):737-48. PubMed ID: 395008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage function in tumor-bearing mice: tumoricidal and chemotactic responses of macrophages activated by infection with Mycobacterium bovis, strain BCG.
    Meltzer MS; Stevenson MM
    J Immunol; 1977 Jun; 118(6):2176-81. PubMed ID: 325142
    [No Abstract]   [Full Text] [Related]  

  • 13. Modulation of host immune response against the L2C guinea pig leukemia.
    Klein DL; Pearson JW
    Fed Proc; 1977 Aug; 36(9):2276-80. PubMed ID: 885264
    [No Abstract]   [Full Text] [Related]  

  • 14. A cell surface marker expressed on cytotoxic peritoneal macrophages and normal lung macrophages.
    Tokunaga T; Akagawa KS; Momoi T
    Adv Exp Med Biol; 1982; 155():429-34. PubMed ID: 6760695
    [No Abstract]   [Full Text] [Related]  

  • 15. Macrophage mediated tumor cell cytotoxicity.
    Kaplan AM; Morahan PS
    Ann N Y Acad Sci; 1976; 276():134-45. PubMed ID: 1071961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro induction of cell-mediated immunity to murine leukemia cells. VII. Methods for augmenting the induction and expression of cytotoxic response in vitro to syngeneic tumors.
    Kedar E; Lupu T; Schwartzbach M; Avraham Y
    J Immunol Methods; 1979; 26(2):157-71. PubMed ID: 155712
    [No Abstract]   [Full Text] [Related]  

  • 17. The use of immunotherapy to enhance tumor rejection immunity in leukemic (L2C) guinea pigs following remission induction with MeCCNU.
    Klein DL; Cote P; Garner W; Wallen RM; Pearson JW
    Leuk Res; 1980; 4(1):185-95. PubMed ID: 7412356
    [No Abstract]   [Full Text] [Related]  

  • 18. Two-step mechanism of macrophage-mediated tumor lysis in vitro.
    Yamazaki M; Shinoda H; Suzuki Y; Mizuno D
    Gan; 1976 Oct; 67(5):741-5. PubMed ID: 797628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunity to transplantable carcinogen-induced fibrosarcomas in B2/B2 chickens. I. Use of bacterial adjuvants in induction of immunity demonstrable in Winn tests.
    Palladino MA; Thorbecke GJ
    Cell Immunol; 1978 Jul; 38(2):336-49. PubMed ID: 354799
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of anti-thymocyte serum, anti-macrophage serum, and latex particles on the therapeutic efficacy of BCG or Corynebacterium liquefaciens (Propionibacterium acnes C7) in syngeneic mice.
    Tanaka T; Nakagawa H; Kato A; Yoshimura M; Fujita H; Kimura K
    Gan; 1977 Feb; 68(1):45-52. PubMed ID: 324858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.